- PCYC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $118.5 million.
- PCYC is up 2.3% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PCYC with the Ticky from Trade-Ideas. See the FREE profile for PCYC NOW at Trade-Ideas More details on PCYC: Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. PCYC has a PE ratio of 111.7. Currently there are 10 analysts that rate Pharmacyclics a buy, no analysts rate it a sell, and 5 rate it a hold. The average volume for Pharmacyclics has been 814,500 shares per day over the past 30 days. Pharmacyclics has a market cap of $9.8 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.09 and a short float of 11.4% with 5.72 days to cover. Shares are up 22.9% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.